Morse, G D <br/><br/>
Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Mar 1996 
 - 767-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.40.3.767  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antiviral Agents--pharmacokinetics<br/>Cross-Over Studies<br/>Didanosine--pharmacokinetics<br/>Drug Interactions<br/>Female<br/>HIV Infections--metabolism<br/>HIV-1<br/>Half-Life<br/>Humans<br/>Intestinal Absorption--drug effects<br/>Male<br/>Middle Aged<br/>Piperazines--pharmacokinetics